Antidepressant-Induced Sexual Dysfunction Support Protocol
Primary Stack
Core supplements with strongest evidencePeruvian root that may improve libido and sexual function; studied specifically for SSRI-induced sexual dysfunction
May improve sexual function in both men and women; studied specifically for SSRI-induced dysfunction
Supporting Stack
Additional supplements for enhanced resultsNitric oxide precursor; may improve blood flow and arousal, particularly in women
Supporting Studies (1)
Improves blood flow; some evidence for improving antidepressant-related sexual dysfunction
Supporting Studies (1)
Cofactor in dopamine synthesis; may help balance neurotransmitters affected by antidepressants
Supporting Studies (1)
Supports testosterone production and sexual function; deficiency impairs libido
Supporting Studies (1)
Adaptogen that may support libido and sexual function; may help with stress-related dysfunction
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Antidepressant-induced sexual dysfunction (AISD) is a very common side effect of antidepressants, particularly SSRIs and SNRIs. It affects 30-70% of patients and includes decreased libido, arousal difficulties, and delayed or absent orgasm. These effects occur because serotonin (which is increased by these antidepressants) can inhibit dopamine and norepinephrine pathways involved in sexual function. AISD is a leading cause of medication non-adherence, which can worsen depression.
CRITICAL: Don't stop your antidepressant without consulting your doctor - this can worsen depression and cause withdrawal symptoms. There are several medical strategies for AISD: dose reduction, drug holidays (for some medications), switching to antidepressants less likely to cause sexual dysfunction (bupropion, mirtazapine, vilazodone), or adding medications like bupropion or PDE5 inhibitors. Discuss these options with your prescriber. These supplements may provide additional support.
* Maca is a Peruvian root vegetable that has been specifically studied for SSRI-induced sexual dysfunction. Clinical trials show it can improve libido and sexual function without affecting serotonin levels or antidepressant efficacy.
* Saffron has shown benefit in randomized trials for both men and women with SSRI-induced sexual dysfunction. It may work through multiple mechanisms including effects on dopamine.
* L-Arginine is a precursor to nitric oxide, which is important for blood flow and arousal. It may be particularly helpful for arousal difficulties.
* Ginkgo Biloba improves blood flow and was initially reported to help AISD, though later controlled trials showed mixed results. Some patients do benefit.
* Vitamin B6 is a cofactor in dopamine synthesis. Since dopamine is important for libido and SSRIs can reduce dopamine activity, supporting dopamine pathways may help.
* Zinc supports testosterone production and overall sexual function. Ensuring adequate zinc status may help.
* Ashwagandha is an adaptogen that has shown benefits for sexual function in both men and women, potentially through stress reduction and hormonal effects.
Expected timeline: Maca and saffron may show benefits within 4-8 weeks of consistent use. Ginkgo and L-arginine may work more quickly for blood flow issues. If supplements don't help significantly, discuss medication strategies with your prescriber.
Clinical Perspective
Antidepressant-induced sexual dysfunction (AISD): decreased libido, arousal difficulty, delayed/absent orgasm occurring during antidepressant treatment. Prevalence: 30-70% with SSRIs/SNRIs (underreported). Mechanism: serotonin inhibits dopamine (reward, motivation) and norepinephrine (arousal); 5-HT2 and 5-HT3 receptor stimulation. Risk highest: SSRIs (paroxetine > sertraline > fluoxetine), SNRIs, TCAs. Lower risk: bupropion, mirtazapine, vilazodone, vortioxetine.
CRITICAL: AISD major cause of non-adherence. Management strategies: 1) Wait (may improve over months), 2) Dose reduction (if depression controlled), 3) Drug holiday (not for fluoxetine/paroxetine - withdrawal), 4) Switch antidepressant (bupropion, mirtazapine), 5) Augmentation (bupropion 150-300mg, buspirone, PDE5 inhibitors for men). Discuss with prescriber before stopping medications. Supplements are ADJUNCTIVE.
* Maca (B-grade): Lepidium meyenii; adaptogen, may affect dopamine. Double-blind trial: 3g maca improved SSRI-induced sexual dysfunction (PMID: 18801111). Systematic review supports use (PMID: 25954318). 1.5-3g daily.
* Saffron (B-grade): Crocus sativus; affects serotonin, dopamine. RCT: 30mg daily improved sexual function in women on fluoxetine (PMID: 23280545). RCT: improved erectile function in men on fluoxetine (PMID: 23145536). 30mg daily.
* L-Arginine (C-grade): NO precursor; vasodilation. Clinical trial: improved female arousal (PMID: 12851125). May help blood flow component. 3-6g daily.
* Ginkgo Biloba (C-grade): Improves microcirculation. Initial open-label positive (PMID: 9611693); later controlled trials mixed. May help some patients. 120-240mg daily.
* Vitamin B6 (C-grade): Dopamine synthesis cofactor. Review: supports neurotransmitter production (PMID: 15159623). 50-100mg daily as P5P.
* Zinc (C-grade): Testosterone, libido. Clinical trial: zinc supports testosterone (PMID: 8875519). 15-30mg daily.
* Ashwagandha (C-grade): Adaptogen; cortisol reduction. RCT: improved sexual function in women (PMID: 26609282). 300-600mg standardized extract daily.
Biomarker targets: Sexual function questionnaires (ASEX, CSFQ), libido, arousal, orgasm latency, patient-reported satisfaction.
Protocol notes: Assess whether depression itself was causing sexual dysfunction (differentiate). Time to onset: usually 1-3 weeks after starting antidepressant. Screen for other causes (hormonal, diabetes, medications, relationship factors). Bupropion augmentation: most evidence (150-300mg daily) - may improve desire and orgasm. Buspirone: 15-60mg daily - some evidence for orgasmic delay. PDE5 inhibitors (sildenafil, tadalafil): effective for erectile dysfunction component, may help women with arousal. If switching antidepressants: bupropion (activating), mirtazapine (minimal sexual effects), vilazodone/vortioxetine (newer agents with lower rates). Trazodone: low doses may help. Exercise improves sexual function. Couples counseling if relationship affected. Drug holidays: only for short half-life drugs, not paroxetine (discontinuation syndrome). Post-SSRI sexual dysfunction (PSSD): rare, persistent sexual dysfunction after stopping SSRI - poorly understood.